Neutralization of a very low molecular weight heparin fraction CY 222 by protamine. in vitro and in vivo study
Doutremepuich, C.; Bonini, F.; de Seze, O.; Toulemonde, F.; Bayrou, B.
Therapie 41(6): 433-436
1986
ISSN/ISBN: 0040-5957 PMID: 3810539 Document Number: 273056
Document emailed within 1 workday
Related Documents
Psuja, P. 1988: Effect of antithrombin IIi on the binding of heparin and its low molecular weight fraction CY 216 with endothelium in vitro Acta Haematologica Polonica 19(3-4): 143-149Harenberg, J.; Stehle, G.; Dempfle, C.E.; von Hodenberg, E.; Heene, D.L. 1989: The pharmacological profile of the low molecular weight heparin 21-23 in man: anticoagulant, lipolytic and protamine reversible effects Folia Haematologica 116(6): 967-980
Malinowska, K.; Iqbal, O.; Hoppensteadt, D.A.; Walenga, J.M.; Fareed, J. 1993: In vivo study of bleeding and antithrombotic effects of low molecular weight heparin ML-009723 Seminars in Thrombosis and Hemostasis 19(Suppl 1): 58-62
Hulin, M.S.; Wakefield, T.W.; Andrews, P.C.; Wrobleski, S.K.; Kadell, A.M.; Downing, L.J.; Stanley, J.C. 1997: Comparison of the hemodynamic and hematologic toxicity of a protamine variant after reversal of low-molecular-weight heparin anticoagulation in a canine model Laboratory Animal Science 47(2): 153-160
Arén, C.; Feddersen, K.; Rådegran, K. 1987: Comparison of two protocols for heparin neutralization by protamine after cardiopulmonary bypass Journal of Thoracic and Cardiovascular Surgery 94(4): 539-541
Poon, M.C.; Hurst, R.E.; Rives, M.S. 1982: Platelet factor four and protamine sulfate neutralization of heparin fractionated according to anionic charge density Thrombosis and Haemostasis 47(2): 162-165
Uzan, A.; Marin, J.; Mardiguian, J.; Trillou, M.; Kiosseff, T.; Rougeot, C. 1987: Comparative pharmacokinetic study, in the dog, of low molecular weight heparin and standard heparin by labelling with 35S Annales Pharmaceutiques Francaises 45(6): 429-437
Tapparelli, C.; Metternich, R.; Gfeller, P.; Gafner, B.; Powling, M. 1995: Antithrombotic activity in vivo of SDZ 217-766, a low-molecular weight thrombin inhibitor in comparison to heparin Thrombosis and Haemostasis 73(4): 641-647
Murty, B.S.; Prakash, V.; Rao, M.S. 1990: Determination of molecular weight and related hydrodynamic parameters of high molecular weight protein fraction from a few oilseeds Indian Journal of Biochemistry and Biophysics 27(5): 295-299
Abou-Saif, A.H.; Alkholy, E.A.; Hammad, R.H.; Hassan, A.H. 2018: The Effect of Low Molecular Weight Heparin in Recurrent Pregnancy Loss: Changes in Radial Uterine Artery Blood Flow and Peripheral Blood NK Cell Fraction Egyptian Journal of Immunology 25(2): 75-85
Neagu, M.; Manda, G.; Constantin, C.; Tanaseanu, C.; Mikhailidis, D.P. 2001: The in vitro effect of a low molecular weight heparin, nadroparin (Fraxiparine), on leukocytes obtained from patients with vascular diseases International Angiology: a Journal of the International Union of Angiology 20(2): 164-173
Ryan, K.E.; Lane, D.A.; Flynn, A.; Shepperd, J.; Ireland, H.A.; Curtis, J.R. 1991: Dose finding study of a low molecular weight heparin, Innohep, in haemodialysis Thrombosis and Haemostasis 66(3): 277-282
Velut, J.G.; Boubli, L.; Lheureux, G.; d'Ercole, C.; Harlé, J.R.; Bagnères, D.; Frances, Y. 2001: Low-molecular-weight heparin prophylaxis during pregnancy: a retrospective study in 119 women Presse Medicale 30(13): 635
Bannon, P.G.; Kim, M.J.; Dean, R.T.; Dawes, J. 1995: Augmentation of vascular endothelial barrier function by heparin and low molecular weight heparin Thrombosis and Haemostasis 73(4): 706-712
Párama, J.A.; Llorens, R.; Sáenz de Buruaga, J.; Rocha, E. 1994: Low-molecular-weight heparin in a patient with heparin-induced thrombocytopenia and a cardiopulmonary bypass Medicina Clinica 102(16): 637-638
Eriksson, E.; Wollter, I.M.; Christenson, B.; Stigendal, L.; Risberg, B. 1988: Heparin and fibrinolysis--comparison of subcutaneous administration of unfractionated and low molecular weight heparin Thrombosis and Haemostasis 59(2): 284-288
Huisse, M.G.; Huet, Y.; Zygelman, M.; Guillin, M.C. 1983: Thrombopenia induced by standard heparin. Therapeutic attempt using a low molecular weight heparin Presse Medicale 12(10): 643
Godoy, I.; Herrera, C.; Zapata, C.; Kunstmann, S.; Abufhele, A.; Corbalán, R. 1998: Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina Revista Medica de Chile 126(3): 259-264
Nakagawa, M. 1993: Heparin, low molecular weight heparin, heparinoid, and antithrombin IIi therapy of disseminated intravascular coagulation Nihon Rinsho. Japanese Journal of Clinical Medicine 51(1): 87-92
Kaiser, B.; Hauptmann, J.; Markwardt, F. 1988: Experimental studies on the antithrombotic and haemorrhagic effects of heparin and a low molecular weight heparin derivative Folia Haematologica 115(1-2): 119-125